Using B12 Supplementation to Improve Quality of Life in Dogs Some dogs entering shelters are emaciated as a result of chronic malnutrition
Both approaches use semaglutide as the active ingredient
Above all, ongoing support is vital
For instance, in April 2025, Pfizer, a US-based pharmaceutical company specializing in metabolic and cardiometabolic drug development, provided an update on its oral GLP-1 receptor agonist candidate, danuglipron, following the completion of once-daily formulation studies intended to improve dosing convenience for patients
These brands are approved by the Food and Drug Administration (FDA) for treating different conditions
Research is necessary to explore any potential role of GLP-1 analogs in treating IBD, including Crohns disease, in the absence of metabolic comorbidities